BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang Z, Li L, Tang Y, Xie D, Wu K, Wei W, Xiao Q. CDK2 positively regulates aerobic glycolysis by suppressing SIRT5 in gastric cancer. Cancer Sci 2018;109:2590-8. [PMID: 29896817 DOI: 10.1111/cas.13691] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Sun X, Wang S, Gai J, Guan J, Li J, Li Y, Zhao J, Zhao C, Fu L, Li Q. SIRT5 Promotes Cisplatin Resistance in Ovarian Cancer by Suppressing DNA Damage in a ROS-Dependent Manner via Regulation of the Nrf2/HO-1 Pathway. Front Oncol 2019;9:754. [PMID: 31456942 DOI: 10.3389/fonc.2019.00754] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
2 Zhu S, Dong Z, Ke X, Hou J, Zhao E, Zhang K, Wang F, Yang L, Xiang Z, Cui H. The roles of sirtuins family in cell metabolism during tumor development. Seminars in Cancer Biology 2019;57:59-71. [DOI: 10.1016/j.semcancer.2018.11.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 13.0] [Reference Citation Analysis]
3 Aventaggiato M, Vernucci E, Barreca F, Russo MA, Tafani M. Sirtuins' control of autophagy and mitophagy in cancer. Pharmacol Ther 2021;221:107748. [PMID: 33245993 DOI: 10.1016/j.pharmthera.2020.107748] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Liu Q, Gao J, Zhao C, Guo Y, Wang S, Shen F, Xing X, Luo Y. To control or to be controlled? Dual roles of CDK2 in DNA damage and DNA damage response. DNA Repair (Amst) 2020;85:102702. [PMID: 31731257 DOI: 10.1016/j.dnarep.2019.102702] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Zhang R, Wang C, Tian Y, Yao Y, Mao J, Wang H, Li Z, Xu Y, Ye M, Wang L. SIRT5 Promotes Hepatocellular Carcinoma Progression by Regulating Mitochondrial Apoptosis. J Cancer 2019;10:3871-82. [PMID: 31333804 DOI: 10.7150/jca.31266] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 5.7] [Reference Citation Analysis]
6 Li L, Dong Z, Shi P, Tan L, Xu J, Huang P, Wang Z, Cui H, Yang L. Bruceine D inhibits Cell Proliferation Through Downregulating LINC01667/MicroRNA-138-5p/Cyclin E1 Axis in Gastric Cancer. Front Pharmacol 2020;11:584960. [PMID: 33390953 DOI: 10.3389/fphar.2020.584960] [Reference Citation Analysis]
7 Wang Y, Jiang R, Wang Q, Li Y, Sun Z, Zhao H. Silencing LINC01021 inhibits gastric cancer through upregulation of KISS1 expression by blocking CDK2-dependent phosphorylation of CDX2. Mol Ther Nucleic Acids 2021;24:832-44. [PMID: 34026327 DOI: 10.1016/j.omtn.2021.01.025] [Reference Citation Analysis]
8 Xiang J, Guan Y, Bhandari A, Xia E, Wen J, Wang O. LINC00511 influences cellular proliferation through cyclin-dependent kinases in papillary thyroid carcinoma. J Cancer 2020;11:450-9. [PMID: 31897240 DOI: 10.7150/jca.35364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chen L, Guo L, Sun Z, Yang G, Guo J, Chen K, Xiao R, Yang X, Sheng L. Monoamine Oxidase A is a Major Mediator of Mitochondrial Homeostasis and Glycolysis in Gastric Cancer Progression. Cancer Manag Res 2020;12:8023-35. [PMID: 32943935 DOI: 10.2147/CMAR.S257848] [Reference Citation Analysis]
10 Yang Y, Yuan G, Xie H, Wei T, Zhu D, Zhu Y, Zheng S. CDK14 expression is elevated in patients with non-small cell lung cancer and correlated with poor prognosis. J Int Med Res 2021;49:3000605211013199. [PMID: 34637340 DOI: 10.1177/03000605211013199] [Reference Citation Analysis]
11 Xia D, Xu P, Luo X, Zhu J, Gu H, Huo D, Hu Y. Overcoming Hypoxia by Multistage Nanoparticle Delivery System to Inhibit Mitochondrial Respiration for Photodynamic Therapy. Adv Funct Mater 2019;29:1807294. [DOI: 10.1002/adfm.201807294] [Cited by in Crossref: 63] [Cited by in F6Publishing: 47] [Article Influence: 21.0] [Reference Citation Analysis]
12 Liang XH, Feng ZP, Liu FQ, Yan R, Yin LY, Shen H, Lu HL. MAPRE1 promotes cell cycle progression of hepatocellular carcinoma cells by interacting with CDK2. Cell Biol Int 2020;44:2326-33. [PMID: 32770827 DOI: 10.1002/cbin.11442] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhu H, Wang G, Zhu H, Xu A. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments. J Cancer 2021;12:3611-25. [PMID: 33995638 DOI: 10.7150/jca.58158] [Reference Citation Analysis]
14 Yu C, Xu H, Wang J. A global and physical mechanism of gastric cancer formation and progression. J Theor Biol 2021;520:110643. [PMID: 33636204 DOI: 10.1016/j.jtbi.2021.110643] [Reference Citation Analysis]
15 Liang Y, Fan Y, Liu Y, Fan H. HNRNPU promotes the progression of hepatocellular carcinoma by enhancing CDK2 transcription. Exp Cell Res 2021;409:112898. [PMID: 34737140 DOI: 10.1016/j.yexcr.2021.112898] [Reference Citation Analysis]
16 Li Y, Xu Q, Yang W, Wu T, Lu X. Oleanolic acid reduces aerobic glycolysis-associated proliferation by inhibiting yes-associated protein in gastric cancer cells. Gene. 2019;712:143956. [PMID: 31271843 DOI: 10.1016/j.gene.2019.143956] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
17 Zhang N, Tan Y, Yan L, Zhang C, Xu M, Guo H, Zhuang B, Zhou L, Xie X. Modulation of Tumor Hypoxia by pH-Responsive Liposomes to Inhibit Mitochondrial Respiration for Enhancing Sonodynamic Therapy. Int J Nanomedicine 2020;15:5687-700. [PMID: 32821097 DOI: 10.2147/IJN.S256038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Leal-Esteban LC, Fajas L. Cell cycle regulators in cancer cell metabolism. Biochim Biophys Acta Mol Basis Dis 2020;1866:165715. [PMID: 32035102 DOI: 10.1016/j.bbadis.2020.165715] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
19 Cheng Y, He C, Wang M, Ma X, Mo F, Yang S, Han J, Wei X. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.Signal Transduct Target Ther. 2019;4:62. [PMID: 31871779 DOI: 10.1038/s41392-019-0095-0] [Cited by in Crossref: 174] [Cited by in F6Publishing: 159] [Article Influence: 58.0] [Reference Citation Analysis]
20 Yao B, Li Y, Niu Y, Wang L, Chen T, Guo C, Liu Q. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5. J Cell Mol Med 2020;24:8718-31. [PMID: 32596968 DOI: 10.1111/jcmm.15503] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
21 Qu X, Zhu L, Song L, Liu S. circ_0084927 promotes cervical carcinogenesis by sponging miR-1179 that suppresses CDK2, a cell cycle-related gene.Cancer Cell Int. 2020;20:333. [PMID: 32699532 DOI: 10.1186/s12935-020-01417-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
22 Tang Z, Li L, Tang Y, Xie D, Wu K, Wei W, Xiao Q. CDK2 positively regulates aerobic glycolysis by suppressing SIRT5 in gastric cancer. Cancer Sci 2018;109:2590-8. [PMID: 29896817 DOI: 10.1111/cas.13691] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
23 Lu X, Yang P, Zhao X, Jiang M, Hu S, Ouyang Y, Zeng L, Wu J. OGDH mediates the inhibition of SIRT5 on cell proliferation and migration of gastric cancer. Exp Cell Res 2019;382:111483. [PMID: 31247190 DOI: 10.1016/j.yexcr.2019.06.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]